4-hydroxy-4-methyl-piperidine-1-carbox ylic acid (4-methoxy-7-morpholin-4-yl-benzothia zol-2-yl)-amide for the treatment of post-traumatic stress disorder

Details for Australian Patent Application No. 2008279169 (hide)

International Classifications

Event Publications

25 February 2010 PCT application entered the National Phase

PCT publication WO2009/015236 Priority application(s): WO2009/015236

19 January 2012 Alteration of Name

The name of the applicant has been altered to Synosia Therapeutics, Inc.

9 February 2012 Assignment before Grant

Synosia Therapeutics, Inc. The application has been assigned to Biotie Therapies, Inc

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.